“Which Factors Help to Determine the Long-Term Response to First-Line Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma: A Turkish Multi-Centre Study”. 2024. Biomolecules and Biomedicine, June. https://doi.org/10.17305/bb.2024.10512.